Actionable news
All posts from Actionable news
Actionable news in LCI: LANNETT COMPANY Inc,

Lannett Receives FDA Approval For Memantine Hydrochloride Oral Solution, 2 mg/mL

PHILADELPHIA, Oct. 14, 2015 /PRNewswire/ -- Lannett Company, Inc. (LCI) today announced that its wholly owned subsidiary, Silarx Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/mL, the therapeutic equivalent to the reference listed drug Namenda® Oral Solution, 2 mg/mL of Forest Pharmaceuticals. According to IMS, for the year ended June 2015 total sales of Memantine Hydrochloride Oral Solution 2 mg/mL at Average Wholesale Price (AWP) were approximately $12 million.

"Memantine Hydrochloride Oral Solution 2 mg/mL is an important product used to treat dementia associated with Alzheimer's disease,"...